Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
about
Mass ivermectin treatment for onchocerciasis: lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity.Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of wormsImpact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra LeoneLymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillanceNeglected tropical diseases: a systematic evaluation of research capacity in NigeriaProgress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial diseaseMapping of Bancroftian Filariasis in Cameroon: Prospects for EliminationEvaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with IvermectinMansonella perstans: safety and efficacy of ivermectin alone, albendazole alone and the two drugs in combinationSustained clearance of Mansonella ozzardi infection after treatment with ivermectin in the Brazilian Amazon.Current evidence on the use of antifilarial agents in the management of bancroftian filariasisLymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.A randomized trial of doxycycline for Mansonella perstans infection.Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillanceLymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone.Public-private partnerships in blindness prevention: reaching beyond the eye.A Systematic Review of the Epidemiology of Mansonelliasis.Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west EthiopiaUpdate on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectinPreventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges.Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens.Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria.Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi.Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of Mansonella ozzardi infection in the Brazilian Amazon.Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria.Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.Progress on elimination of lymphatic filariasis in Sierra Leone.
P2860
Q24813874-95F0D67F-D532-450E-815E-CFC6B0CA8ADCQ26998808-3E1EA5EF-8759-4AA6-AAC1-9C1682757706Q28533882-D07A0771-028D-4758-96E7-83A9E9EEB8F7Q28536890-9AC51A56-3979-4147-80A1-B1F50855370AQ28541931-CDFF92F2-27C9-4457-A311-E889736298D9Q28545108-20E4DDF8-CC99-4198-B1FB-53D42B905D82Q28547792-97ADA3B4-D1F2-4783-A500-4FB57A83FB76Q28554797-03B82D5F-784A-4C94-B550-5841FF9C47DBQ29300354-5B786C09-E005-4611-ADA5-30788B235BA3Q33719659-D681212E-EE8D-42FD-B76D-96B27264A85BQ34479159-78126A16-F727-469B-9022-51739549885EQ34517923-346FE939-6D05-401D-B64B-3FC2C5CF8466Q34612544-C9526702-5340-4622-BC8F-DC8408AFF8E7Q35241468-5ECCBA33-9D83-4D09-9EF1-0D4C3A40866BQ35712047-1385C85E-8ADD-47E8-AEF0-A716C2E99074Q36320399-8C107B22-9F24-449A-B1A6-F503D74D907BQ36398118-9C2DC03E-273E-4DF8-90FC-68886AE8CE1FQ36622829-473D92D2-22E6-454E-A5BB-4833C7D44B02Q36949973-4DAFEB14-B835-4AF3-A771-EEE98BDFD769Q37037409-5EB5E110-865E-4512-8D63-B5E0BE34FF7AQ38881064-AE1517E7-72D1-4F86-A58E-08575E32D271Q39154373-2878B61D-E7F1-49FC-A051-2871255659B1Q44164360-85428B8D-F73B-4ADC-8D32-16DD2A564E09Q46716665-D29F0AFB-A927-4AB2-AD63-41770C397A70Q50126969-773D7765-2AEB-40D3-9FD9-5B74CE9B3918Q54963442-7B2708ED-4B21-477A-B84E-67650607FCB4Q55334206-59AD293D-52FC-48A6-99ED-10CB62465D4DQ55491807-58B6F09B-9D21-46D4-BBAE-5A9D632D920F
P2860
Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Impact of long-term ivermectin ...... tegic and policy implications.
@en
Impact of long-term ivermectin
@nl
type
label
Impact of long-term ivermectin ...... tegic and policy implications.
@en
Impact of long-term ivermectin
@nl
prefLabel
Impact of long-term ivermectin ...... tegic and policy implications.
@en
Impact of long-term ivermectin
@nl
P2093
P2860
P1476
Impact of long-term ivermectin ...... tegic and policy implications.
@en
P2093
P2860
P304
P356
10.1179/000349803225002462
P577
2003-12-01T00:00:00Z